ecrin-mdr-crcClinical2023IPD Sharing (as of April 2023): NoMetastatic Colorectal CancerColorectal NeoplasmsMetastatic Colorectal CancerColorectal NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2742027Australia4IrinotecanPembrolizumabECRIN MDRRecruitingfalseMNK Inhibitor AUM001 in Combination With Either Pembrolizumab or Irinotecan to Treat Metastatic Colorectal CancerThe study is a 2-part study of AUM001 alone on in combination with Pembrolizumab/Irinotecan in patients with CRC.2023-04-152742027NCT05462236